Treat It: Revolutionising Access to Medical Cannabis for Chronic Pain Patients in the UK

Treat It: Revolutionising Access to Medical Cannabis for Chronic Pain Patients in the UK

Treat It, a pioneering online primary healthcare provider, is set to transform the medical cannabis landscape in the United Kingdom. By seamlessly connecting patients with their medical records, physicians, and dispensing pharmacies, Treat It aims to provide a convenient and secure alternative to conventional pain management methods.

The Need for Alternative Treatments

Chronic pain affects an estimated 8 million people in the UK, with a significant proportion (24%) being prescribed opioids for treatment. Conventional pharmaceutical therapies, while widely used, often result in unwanted side effects and can leave patients frustrated with their care. As a result, there is a growing demand for alternative treatments that can address chronic pain issues more effectively.

Treat It’s Approach

Treat It has identified a range of conditions that may benefit from medical cannabis treatments, including migraine, sciatica, cancer, neuropathy, and various forms of joint, back, and neck pain. By providing patients with easy and secure access to medical cannabis treatments, Treat It aims to empower patients and deliver personalised care right to their doorsteps.

To ensure quality care, Treat It physicians must be registered with the UK’s General Medical Counsel and adhere to the National Institute for Health and Care Excellence guidelines.

Costs and Accessibility

Patients seeking consultation through Treat It will be charged an initial fee of £79.99 (approximately $96). Prescription costs will vary depending on individual needs. This innovative approach to medical cannabis care is designed to improve patient access and reduce wait times for treatment, which can currently take up to 13 weeks for a referral, according to the British Pain Society.

Medical Cannabis Research and Legality in the UK

Although more research is needed, there is growing evidence to suggest that cannabis has therapeutic potential in managing symptoms of various conditions, such as multiple sclerosis (MS). In the UK, the cannabis-based oral spray Sativex (nabiximols) is the only licensed form of medical cannabis for MS, used as an add-on medication for muscle stiffness and spasms.


Treat It is poised to revolutionise access to medical cannabis for chronic pain patients in the UK by providing a secure, convenient, and patient-centered alternative to traditional pain management methods. With ongoing research and increased awareness of the potential benefits of cannabis-based treatments, Treat It could play a significant role in improving the quality of life for millions of people suffering from chronic pain.

Search our blog:

Further Reading:

Leave a Reply

%d bloggers like this: